What is the production capacity of the factory?

The factory has a capacity of 300,000 units per month with advanced production lines.

Silent 47lpm 1.4bar Piston Mini Air Compressor for 3liter Oxygen Concentrator

Name: Silent 47lpm 1.4bar Piston Mini Air Compressor for 3liter Oxygen Concentrator
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 2092044425

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$45.00-55.00

100 Pieces

Sample price:US$70.00/piece.Request sample

Product profile

Customization

Available

After-sales Service

on Line Support and Free Spare Parts

Air Flow

47 L/[email protected]

Model NO.

ZGK200-47-218

Rated Pressure

1.4 Bar

Noise

≤53dB(a)

Power Source

AC Power

Power

210W

Voltage

220V 50Hz

Speed

1400rpm

Temperature

50° to 104°f(10° to 40°c)

Thermal Protector

145°c

Dimension

218X99X165mm

Net Weight

4.0 Kg

Brand Name

OEM

Package

Honeycomb Packaging

Certificate

ETL

HS Code

8414809090

Production Capacity

1000000 Piece/Year

Key features

OEM/ODM Customization: Supports customized imported TPI/NSK bearings and piston rings for high-end development.

Safety Certified: Complies with RoHS standards and holds ETL safety certification for reliable operation.

Strong R&D Capability: Over 20 invention patents with full vertical integration from motor design to assembly.

Large Scale Production: Capacity of 300,000 units per month with 8 motor lines and 16 die-casting machines.

Trusted by Global Brands: Vendor for Omron, Panasonic, Invacare, and Nidek Medical with strict quality control.

Comprehensive After-Sales: Provides online support and free spare parts to ensure long-term product reliability.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤9.16hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.